(Press-News.org) Could cocoa extract supplements rich in cocoa flavanols reduce inflammation and, in turn, prevent age-related chronic diseases? In a new study from the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), investigators from Mass General Brigham and their colleagues looked at changes in five age-related markers of inflammation among participants who received daily cocoa supplements over several years. They found that hsCRP—an inflammatory marker that can signal increased risk of cardiovascular disease—decreased in participants taking the cocoa extract supplement, suggesting its anti-inflammatory potential may help explain its heart-protective effects. Their results are published in Age and Ageing.
Nutritional interventions have become an increasingly attractive solution for slowing inflammatory aging, so called “inflammaging.” Cocoa extract has been shown in previous, smaller studies to reduce inflammatory biomarkers, thanks to flavanols—small, bioactive compounds found not only in the cocoa bean but also berries, grapes, tea, and other plant-based foods. To bridge the gap between these studies and humans, researchers launched the large-scale COSMOS trial, which examines the effects of cocoa extract on cardiovascular disease, and whether inflammaging may explain those effects.
“Our interest in cocoa extract and inflammaging started on the basis of cocoa-related reductions in cardiovascular disease,” said corresponding author Howard Sesso, ScD, MPH, associate director of the Division of Preventive Medicine and associate epidemiologist at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system. “We also appreciate the important overlap between healthy aging and cardiovascular health, where aging-related inflammation can harden arteries and lead to cardiovascular disease. Because of that, we wanted to see whether multi-year cocoa extract supplementation versus a placebo could modulate inflammaging—and the data suggests it does.”
Between 2014 and 2020, Brigham and Women’s Hospital led the COSMOS trial, a large-scale, randomized, double-blind, placebo-controlled clinical trial with 21,442 participants over 60 years old, finding that cocoa extract supplementation decreased cardiovascular disease mortality by 27%.
In this new study, researchers collected and analyzed blood samples of 598 COSMOS participants to measure several inflammaging biomarkers: three pro-inflammatory proteins (hsCRP, IL-6, and TNF-α), one anti-inflammatory protein (IL-10), and one immune-mediating protein (IFN-γ). Comparing changes in these biomarkers measured at baseline, 1, and 2 years follow-up, hsCRP levels decreased by 8.4% each year compared with placebo, while the other biomarkers remained relatively consistent or increased modestly.
“Interestingly, we also observed an increase in interferon-γ, an immune-related cytokine, which opens new questions for future research,” said senior author Yanbin Dong, MD/PhD, Director of the Georgia Prevention Institute (GPI) and cardiologist/population geneticist at the Medical College of Georgia/Augusta University. “While cocoa extract is not a replacement for a healthy lifestyle, these results are encouraging and highlight its potential role in modulatingi nflammation as we age.
The decrease in hsCRP may help explain the cardio-protective effects seen with cocoa extract supplement in the larger COSMOS trial, where participants experienced a reduction in cardiovascular disease death. Researchers said that changes in the other inflammaging markers, including a small reduction in IL-6 observed in female but not male participants, warrant additional study. The team will continue to evaluate the COSMOS trial to determine whether the cocoa - and multivitamin - regimens can curb more severe inflammaging, as well as other important aging-related health outcomes.
“This study calls for more attention to the advantage of plant-based foods for cardiovascular health, including cocoa products rich in flavanols,” added Sesso. “It reinforces the importance of a diverse, colorful, plant-based diet—especially in the context of inflammation.”
Authorship: In addition to Sesso, Mass General Brigham authors include Sidong Li, Rikuta Hamaya, Allison Clar, Pamela M. Rist, and JoAnn E. Manson. In addition to Dong, Augusta University authors include Haidong Zhu and Ying Huang.
Disclosures: Manson and Sesso received investigator-initiated grants from Mars Edge, a segment of Mars Incorporated dedicated to nutrition research and products, for infrastructure support and donation of COSMOS study pills and packaging, and Pfizer Consumer Healthcare (now Haleon) for donation of COSMOS study pills and packaging during the conduct of the study. Sesso additionally reported receiving investigator-initiated grants from Pure Encapsulations, American Pistachio Growers, and Haleon, and honoraria and/or travel for lectures from the Council for Responsible Nutrition, BASF, Haleon, and NIH during the conduct of the study. No other authors reported any conflicts of interests for this study
Funding: This work is supported by the National Institutes of Health (HL157665). The COcoa Supplement and Multivitamin Outcomes Study (COSMOS) is supported by an investigator-initiated grant from Mars Edge, a segment of Mars dedicated to nutrition research and products, which included infrastructure support and the donation of study pills and packaging. Pfizer Consumer Healthcare (now Haleon) provided support through the partial provision of study pills and packaging. COSMOS is also supported in part by the National Institutes of Health (AG050657, AG071611, and EY025623). Neither company had a role in the trial design or conduct, data collection, data analysis, or manuscript preparation or review.
Paper cited: Li S et al. “Effects of Two-year Cocoa Extract Supplementation on Inflammaging Biomarkers in Older US Adults: Findings from the COSMOS Randomized Clinical Trial” Age and Ageing DOI: 10.1093/ageing/afaf269
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
About The Study: The findings of this study suggest that metabolic bariatric surgery was associated with more weight loss at lower ongoing costs compared with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in class II and III obesity. Further study is needed to determine if metabolic bariatric surgery should still be considered the last resort in treating obesity.
Corresponding Author: To contact the corresponding author, George M. Eid, MD, email george.eid@ahn.org.
To access the embargoed study: Visit our For The Media website ...
About The Study: The results of this cohort study suggest that there is a decreased risk of skin cancer among patients treated with nicotinamide, with the greatest effect seen when initiated after the first skin cancer. Nicotinamide is a vitamin B3 derivative that is sold as an over-the-counter medication. JAMA Dermatology Editor in Chief Kanade Shinkai, MD, PhD, selected the paper as a highlight for journalists. Once published, the paper will be accompanied by a podcast and short video.
Corresponding Author: To contact ...
Researchers at Washington University School of Medicine in St. Louis have identified a novel way brown fat — an energy-burning form of fat — can rev the body’s metabolic engine, consuming cellular fuel and producing heat in a way that improves metabolic health. The study, in mice, reveals new avenues to exploit brown fat to treat metabolic diseases, such as insulin resistance and obesity.
The study is published Sept. 17 in Nature.
Brown fat is known for its ability to turn energy (calories) from food into heat. In contrast, white fat stores energy for later use while muscle makes energy immediately ...
A USC Stem Cell-led research team has achieved a major step forward in the effort to build mouse and human synthetic kidneys. In a new paper published in Cell Stem Cell, the scientists describe generating more mature and complex lab-grown kidney structures, or organoids, than ever before.
“This is a revolutionary tool for creating more accurate models for studying kidney disease, which affects one in seven adults,” said corresponding author Zhongwei Li, associate professor of medicine, and stem cell biology and regenerative medicine at the Keck School of Medicine of USC. “It’s also a milestone ...
When do people behave badly? Extensive research in behavioral science has shown that people are more likely to act dishonestly when they can distance themselves from the consequences. It's easier to bend or break the rules when no one is watching—or when someone else carries out the act. A new paper from an international team of researchers at the Max Planck Institute for Human Development, the University of Duisburg-Essen, and the Toulouse School of Economics shows that these moral brakes weaken even further when people delegate tasks to AI. Across 13 studies involving more than ...
Research supported by the National Institutes of Health (NIH) shows that repeated head impacts from contact sports can cause early and lasting changes in the brains of young- to middle-aged athletes. The findings show that these changes may occur years before chronic traumatic encephalopathy (CTE) develops its hallmark disease features, which can now only be detected by examining brain tissue after death.
“This study underscores that many changes in the brain can occur after ...
EMBARGOED by Nature until 11 a.m. ET, September 17, 2025
Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu
BU Study of Young Athletes Finds Neurodegeneration Might Begin Before CTE
These results have the potential to significantly change our perspective on contact sports.
(BOSTON) This fall, tens of millions of people will be at risk for chronic traumatic encephalopathy (CTE), a degenerative brain disease caused by repeated head impacts from contact sports like football, soccer, and ice hockey, or military service. Researchers have long ...
Dr. Carl F. Nathan, the R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, has been awarded the David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine by the National Academy of Medicine.
Established in 2004, the prestigious award honors innovative biomedical scientists who have advanced global health with an exceptional biomedical research discovery and translation that has fundamentally enriched the scientific community’s understanding of human biology and disease, leading to a significant reduction of disease burden and improvement in ...
WASHINGTON — Researchers have developed a new type of microscope that can acquire extremely large, high-resolution pictures of non-flat objects in a single snapshot. This innovation could speed up research and medical diagnostics or be useful in quality inspection applications.
“Although traditional microscopes assume the sample is perfectly flat, real-life samples such as tissue sections, plant samples or flexible materials may be curved, tilted or uneven,” said research team ...
SAN ANTONIO —September 17, 2025 — Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UT San Antonio) will flight test novel electrolyzer technology to better understand chemical processes associated with bubble formation in low gravity. Designed to solve future space mission challenges, the project, led by SwRI’s Kevin Supak and UT San Antonio’s Dr. Shrihari Sankarasubramanian, is supported by a $125,000 grant from the Connecting through Research Partnerships (Connect) program, ...
